AHA Says HRSA Vastly Underestimates Costs 340B Rebate Pilot Program Will Inflict on Hospitals, Urges Agency to Delay Implementation
2 Articles
2 Articles
AHA says HRSA vastly underestimates costs 340B Rebate Pilot Program will inflict on hospitals, urges agency to delay implementation
The anticipated burdens on hospitals to comply with the Health Resources and Services Administration’s 340B Rebate Pilot Program far exceed the agency’s estimates, and HRSA should delay the program’s implementation, the AHA today told the agency. “HRSA has greatly underestimated the costs that its 340B Rebate Pilot Program will inflict on hospitals, and it has not addressed the many operational challenges that covered entities identified in the…
A Coming Storm—or Opportunity: How the 340B Rebate Pilot and Medicare MFP Could Strain or Strengthen the Drug Supply Chain - 340B Report
SPONSORED CONTENT The U.S. drug pricing infrastructure is entering a transformative era. On August 1, 2025, the Health Resources and [...] The post A Coming Storm—or Opportunity: How the 340B Rebate Pilot and Medicare MFP Could Strain or Strengthen the Drug Supply Chain appeared first on 340B Report.
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium